A recent report published by Infinium Global Research on bleeding disorders treatment market provides in depth analysis of segments and sub-segments in global as well as regional bleeding disorders treatment market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional bleeding disorders treatment market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global bleeding disorders treatment market. According to report the global bleeding disorders treatment market is projected to grow at a CAGR of 8.5% over the forecast period of 2017-2023.
Bleeding disorders refer to the disorders in blood coagulation conditions due to which prolonged bleeding can occur due to injury. This report provides insights into the bleeding disorders treatment market globally and regionally. The global bleeding disorders treatment market is expected to be primarily driven by factors such as rising global base of geriatric population, rising R&D Investment for development of hemophilia products, increasing preference for prophylactic treatment, and increasing number of diagnosed hemophilia patients.
Figure 1: Global Bleeding Disorders Treatment Market by Value 2015-2023
The report on global bleeding disorders treatment market covers segments such as, type and drug class. On the basis of type the global bleeding disorders treatment market is categorized into hemophilia A, hemophilia B, von willebrand disease and others. On the basis of drug class the global bleeding disorders treatment market is categorized into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Bleeding Disorders Treatment Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global bleeding disorders treatment market such as, Baxalta, Bayer Pharmaceuticals, Novo Nordisk A/S, Pfizer Inc., Biogen Idec, CSL Behring, Grifols, Octapharma, Alnylam Pharmaceuticals and Xenetic Biosciences, Inc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global bleeding disorders treatment market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of bleeding disorders treatment market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the bleeding disorders treatment market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the bleeding disorders treatment market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter